Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm driven by a fusion gene, encoding for the chimeric protein BCR-ABL, with constitutive tyrosine kinase (TK) activity. Here, ABL1 is linked to myeloproliferative disorder.